Ventas (VTR) | Stock Overview & Key Data
Ventas Performance Comparison
Stock Range
Today's Range
Low: $69.57
High: $70.49
on October 3, 2025
52 Week Range
Low: $56.68
High: $71.36
on January 7, 2025
on April 3, 2025
All-Time High: $96.05 on May 20, 2013
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$28.9B
EPS
0.33
P/E Ratio (TTM)
194.30
Forward P/E
400.75
P/B Ratio
2.52
PEG Ratio
400.75
Div. Yield
2.92%
ROE
1.38%
Beta
0.974
Debt to Equity
108.90
Financial Highlights
Profitability
Gross Margin
42.15%
Operating Margin
14.15%
Profit Margin
2.82%
Returns and Earnings
Return on Assets (TTM)
1.92%
Return on Equity (TTM)
1.38%
EBITDA
$2.0B
Net Income (TTM)
$142.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$11.57
Quarterly Revenue Growth (YoY)
14.10%
Quarterly Earnings Growth (YoY)
13.18%
Dividend Information
Last 12-Month Dividend
$1.83
Current Dividend Yield
2.92%
3-Year Average Dividend Yield
0.91%
3-Year Average Annual Dividend
$1.66
3-Year Total Dividends
$4.98
Ex-Dividend Date
March 31, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Ventas VTR | 28.94B Large-cap | 1.10% | 3.42% | 10.85% | 0.23% | 20.36% | 11.56% | 84.94% | 56.17% |
| Welltower WELL | 117.07B Large-cap | 0.08% | 4.55% | 14.58% | 14.83% | 40.35% | 39.41% | 198.70% | 210.85% |
| Healthpeak DOC | 13.46B Large-cap | 2.27% | 9.25% | 6.31% | -0.46% | -3.92% | -13.43% | 37.47% | 4.99% |
| Omega Healthcare OHI | 12.34B Large-cap | -1.65% | -3.13% | 12.22% | 6.47% | 8.66% | 4.57% | 39.92% | 32.53% |
| CareTrust REIT CTRE | 7.93B Mid-cap | 1.98% | 4.97% | 13.75% | 23.02% | 33.82% | 16.86% | 110.75% | 91.22% |
| American Healthcare AHR | 6.89B Mid-cap | -2.97% | -2.60% | 10.33% | 34.54% | 47.39% | 63.27% | 211.74% | 211.74% |
Ownership & Short Interest
Insider Ownership
0.59%
Institutional Ownership
100.44%
Shares Short
14M
Short Ratio
4.13
Short % of Shares Outstanding
3.56%
Average 10-Day Volume
3M
Average 90-Day Volume
3M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is VTR's 52-week high and low?
- In the last 52 weeks, Ventas reached a high of $71.36 (on April 3, 2025) and a low of $56.68 (on January 7, 2025).
- What is the market cap and P/E ratio for VTR?
- Curious about Ventas's size and valuation? Its market capitalization stands at 28.94B. When it comes to valuation, the P/E ratio (trailing twelve months) is 194.30, and the forward P/E (looking ahead) is 400.75.
- Does VTR pay dividends? If so, what's the yield?
- Yes, Ventas is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.92%, and the company has paid an average of $1.66 per share annually over the past 3 years.
- Who are Ventas's main competitors or similar companies to consider before investing?
When looking at Ventas, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Welltower
WELL117.07B Real Estate REIT - Healthcare Facilities 39.41% 198.70% Healthpeak
DOC13.46B Real Estate REIT - Healthcare Facilities -13.43% 37.47% Omega Healthcare
OHI12.34B Real Estate REIT - Healthcare Facilities 4.57% 39.92% CareTrust REIT
CTRE7.93B Real Estate REIT - Healthcare Facilities 16.86% 110.75% American Healthcare
AHR6.89B Real Estate REIT - Healthcare Facilities 63.27% 211.74% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Ventas Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Ventas's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.38%, the Debt to Equity ratio from the most recent quarter is 108.90, and its Gross Profit Margin stands at 42.15%.
- What is the recent revenue and earnings growth for VTR?
- Looking at Ventas's growth, its revenue over the trailing twelve months (TTM) was $5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.10%, and quarterly earnings saw a YoY growth of 13.18%.
- How much of VTR stock is held by insiders and institutions?
- Wondering who owns Ventas stock? Company insiders (like executives and directors) hold about 0.59% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 100.44%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.